Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Subst Abuse Treat. 2021 Mar 3;127:108344. doi: 10.1016/j.jsat.2021.108344

Appendix A.

Baseline characteristics of all clients enrolled in the syringe services program (N=1,059).

Characteristic Longitudinal cohort (n=115)
(n,%)
Baseline-only cohort (n=945)
(n,%)
p-value
Age (median, IQR) 38 (32–47) 36 (30–44) 0.053
Biological Sex 0.71
 Male 88 (76.5) 700 (75.0)
 Female 27 (23.5) 234 (25.0)
Race/Ethnicity 0.46
 Non-Hispanic White 57 (50.4) 504 (55.5)
 Non-Hispanic Black 5 (4.4) 49 (5.4)
 Hispanic 51 (45.1) 356 (39.2)
Housing Status <0.01
 Currently experiencing homelessness 56 (58.3) 311 (34.3)
Drugs Injected
 Heroin 97 (84.4) 689 (72.5) <0.01
 Cocaine 30 (26.1) 260 (27.5) 0.79
 Methamphetamine 10 (8.7) 166 (17.6) 0.02
 Crack-cocaine 11 (9.6) 80 (8.5) 0.67
 Speedball 25 (21.7) 164 (17.4) 0.23
 Fentanyl 17 (14.8) 160 (16.9) 0.59
HIV-positive 11 (9.7) 91 (9.8) 0.76
HCV-positive 50 (45.1) 386 (42.3) 0.53
Average number of injections per day <0.01
 <5 64 (57.7) 342 (39.5)
 ≥5 47 (42.3) 523 (60.5)
Injection in public places (e.g. streets) <0.01
 Yes 64 (55.7) 329 (34.8)
 No 51 (44.3) 616 (65.2)
Share injection equipment <0.01
 Yes 51 (47.2) 282 (29.8)
 No 57 (52.8) 663 (70.2)
Reuse syringes <0.01
 Yes 93 (94.9) 600 (67.7)
 No 5 (5.10) 286 (32.3)